HRT Compounding & Bioidentical Hormones 3

Question 1

What is the primary criticism major medical organizations such as ACOG raise about compounded bioidentical HRT?

Accepted Answer

Lack of long-term safety and efficacy data from large randomized controlled trials

Answer

Major medical organizations criticize compounded BHRT primarily because it lacks the large randomized controlled trial data that FDA-approved HRT products must demonstrate to establish long-term safety and efficacy.

Question 2

A significant limitation of saliva hormone testing commonly used in BHRT practices is that it:

Accepted Answer

Shows high variability and lacks standardization compared to serum testing

Answer

Saliva hormone testing has significant limitations including high inter-laboratory variability, lack of standardization, and results that may not accurately reflect physiologically active serum hormone levels.

Question 3

DHEA (dehydroepiandrosterone) is sometimes included in compounded HRT regimens primarily because it:

Accepted Answer

Is a precursor hormone convertible to estrogen and testosterone

Answer

DHEA is an adrenal precursor hormone that the body can peripherally convert into both estrogen and testosterone, making it a useful component in supporting overall hormone balance in comprehensive HRT programs.

Question 4

Why is a valid patient-practitioner relationship required under Section 503A for compounded HRT prescriptions?

Accepted Answer

It is a legal requirement for the compounding exemption and ensures medically appropriate use

Answer

Section 503A requires a valid patient-practitioner relationship and an individual patient-specific prescription for a compounding pharmacy to qualify for exemptions from certain FDA manufacturing and labeling requirements.

Question 5

What distinguishes a 503B outsourcing facility from a 503A traditional compounding pharmacy?

Accepted Answer

503B facilities are FDA-registered, can produce large batches, and are not required to have individual patient prescriptions

Answer

Section 503B outsourcing facilities are voluntarily registered with the FDA, may produce large quantities without individual prescriptions, and are subject to federal cGMP standards and regular FDA inspections.

HRT - Hormone Replacement Therapy Certification Practice Test

HRT - Hormone Replacement Therapy Certification Practice Test

HRT Compounding & Bioidentical Hormones 3